The Latest Cardiac and Vascular News
Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral […]
Feb. 7, 2018 21:06 UTC Cardiovascular Systems, Inc. Appoints Jeff Points as Chief Financial Officer Larry Betterley to Retire in August 2018 ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that Jeff Points was named Chief Financial Officer […]
First Patient Treated by Dr. Shigeru Saito at Shonan Kamakura General Hospital ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced […]
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced two new partnerships broadening the company’s product portfolio. CSI is now […]
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, October 25, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $49.7 million were flat versus first quarter last year Gross margin increased to 81.5% […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 first-quarter conference call on Wednesday, October 25, 2017, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman, President and Chief Executive […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) today said that the impact of Hurricanes Harvey and Irma on procedure volumes in the greater Houston area and throughout Florida will reduce fiscal 2018 first-quarter revenues. “Our thoughts go out to […]
This study recaps one year and 1200 patients including use of the Diamond Back 360. Cardiovascular Systems touts 1-year, sub-analysis data from Liberty PVI study AUGUST 10, 2017 BY FINK DENSFORD, MassDevice Cardiovascular Systems (NSDQ:CSII) today released both 1-year and a sub-analysis results from […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (NASDAQ: CSII): Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal third quarter […]
Cardiovascular Systems, Inc. Receives Approval for the Diamondback 360® Coronary Orbital Atherectomy System (OAS) Micro Crown in the United States OAS Micro Crown Approved to Treat Severely Calcified Coronary Lesions Only Atherectomy Device Designed to Both Pilot Tight Lesions and […]
